Forcefield Therapeutics
8 employees on LinkedIn · 2 known investors
Forcefield Therapeutics develops cardioprotective proteins for the treatment of cardiac disease, with an initial focus on myocardial infarction (heart attack). It holds an exclusive licence to these proteins and operates a virtual business model working with strategic and operational partners.
Founders & leadership
J
John
Investors · 2
Frequently asked questions
- What does Forcefield Therapeutics do?
- Forcefield Therapeutics develops cardioprotective proteins for the treatment of cardiac disease, with an initial focus on myocardial infarction (heart attack). It holds an exclusive licence to these proteins and operates a virtual business model working with strategic and operational partners.
- Who are Forcefield Therapeutics's investors?
- Forcefield Therapeutics's investors include Syncona, Roche Venture Fund.